Your browser doesn't support javascript.
loading
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.
Hitt, Ricardo; Mesía, Ricard; Lozano, Alicia; Iglesias Docampo, Lara; Grau, Juan J; Taberna, Miren; Rubió-Casadevall, Jordi; Martínez-Trufero, Javier; Morillo, Edel Del Barco; García Girón, Carlos; Vázquez Estévez, Sergio; Cirauqui, Beatriz; Cruz-Hernández, Juan Jesús.
Affiliation
  • Hitt R; Medical Oncology Service, University Hospital Severo Ochoa, Leganés, Madrid, Spain. Electronic address: rhitt@telefonica.net.
  • Mesía R; Medical Oncology Department, Institut Català d́Oncologia (ICO), Hospitalet, Barcelona, Spain.
  • Lozano A; Radiotherapy Oncology Department, Institut Català d́Oncologia (ICO), Hospitalet, Barcelona, Spain.
  • Iglesias Docampo L; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.
  • Grau JJ; Medical Oncology Department, Hospital Clinic, Barcelona, Spain.
  • Taberna M; Medical Oncology Department, Institut Català d́Oncologia (ICO), ONCOBELL, IDIBELL, Hospitalet, Barcelona, Spain.
  • Rubió-Casadevall J; Medical Oncology Department, University Hospital Josep Trueta, Institut Català d'Oncologia (ICO), Girona, Spain.
  • Martínez-Trufero J; Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Morillo EDB; Medical Oncology Service, University Hospital of Salamanca- IBSAL (Biomedical Research Institute of Salamanca), Salamanca, Spain.
  • García Girón C; Medical Oncology Service, Hospital Universitario de Burgos, Burgos, Spain.
  • Vázquez Estévez S; Medical Oncology Service, Universitary Hospital Lucus Augusti< Lugo, Spain.
  • Cirauqui B; Medical Oncology Department, Institut Català d'Oncologia (ICO), Badalona Applied Research Group in Oncology (B-ARGO), Badalona, Spain.
  • Cruz-Hernández JJ; Medical Oncology Service, University Hospital of Salamanca- IBSAL (Biomedical Research Institute of Salamanca), Salamanca, Spain.
Oral Oncol ; 134: 106087, 2022 11.
Article in En | MEDLINE | ID: mdl-36126605
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Head and Neck Neoplasms Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Oral Oncol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Head and Neck Neoplasms Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Oral Oncol Year: 2022 Document type: Article